AAV Hybrid Serotypes: Improved Vectors for Gene Delivery
Open accessThe DOI matches its Crossref record; 106 of the 108 references it cites were found in a registry or an index.
Abstract
In recent years, significant efforts have been made on studying and engineering adeno-associated virus (AAV) capsid, in order to increase efficiency in targeting specific cell types that are non-permissive to wild type (wt) viruses and to improve efficacy in infecting only the cell type of interest. With our previous knowledge of the viral properties of the naturally occurring serotypes and the elucidation of their capsid structures, we can now generate capsid mutants, or hybrid serotypes, by various methods and strategies. In this review, we summarize the studies performed on AAV retargeting, and categorize the available hybrid serotypes to date, based on the type of modification: 1) transcapsidation, 2) adsorption of bi-specific antibody to capsid surface, 3) mosaic capsid, and 4) chimeric capsid. Not only these hybrid serotypes could achieve high efficiency of gene delivery to a specific targeted cell type, which can be better-tailored for a particular clinical application, but also serve as a tool for studying AAV biology such as receptor binding, trafficking and genome delivery into the nucleus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AAV2 is the most extensively studied AAV serotype, including the functional characterization of all charged residues in the VP (Choi et al., 2005; Grieger et al., 2006; Lochrie et al., 2006; Mietzsch et al., 2019; Wang et al., 2019; Wu et al., 2000).”
From Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2 (2020) · cites this paper as Choi et al., 2005
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406
Self-citationGene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202
Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues
Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X., & Wilson, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6381-6388.2004 · Cited by 1,070
Adenovirus-Associated Defective Virus Particles
Atchison, R. W., Casto, B. C., & Hammon, W. M. (1965) · Science · doi:10.1126/science.149.3685.754 · Cited by 1,004
Xiao, X., Li, J., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8098-8108.1996 · Cited by 912
Self-citationLewis, P. F., & Emerman, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.510-516.1994 · Cited by 797
Rabinowitz, J. E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X., & Samulski, R. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.791-801.2002 · Cited by 762
Self-citationUse of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells
Muzyczka, N. (1992) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-75608-5_5 · Cited by 754
McCarty, D., Monahan, P., & Samulski, R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301514 · Cited by 735
Self-citationαVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection
Summerford, C., Bartlett, J. S., & Samulski, R. J. (1999) · Nature Medicine · doi:10.1038/4768 · Cited by 711
Self-citationRNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia
Xia, H., Mao, Q., Eliason, S. L., Harper, S. Q., Martins, I. H., Orr, H. T., Paulson, H. L., Yang, L., Kotin, R. M., & Davidson, B. L. (2004) · Nature Medicine · doi:10.1038/nm1076 · Cited by 652
The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
Xie, Q., Bu, W., Bhatia, S., Hare, J., Somasundaram, T., Azzi, A., & Chapman, M. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162250899 · Cited by 612
Herzog, R. W., Yang, E. Y., Couto, L. B., Hagstrom, J. N., Elwell, D., Fields, P. A., Burton, M., Bellinger, D. A., Read, M. S., Brinkhous, K. M., et al. (1999) · Nature Medicine · doi:10.1038/4743 · Cited by 554
McCarty, D. M., Fu, H., Monahan, P. E., Toulson, C. E., Naik, P., & Samulski, R. J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302134 · Cited by 547
Self-citationGene therapy vectors based on adeno-associated virus type 1
Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G., & Wilson, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3994-4003.1999 · Cited by 541
Hoggan, M. D., Blacklow, N. R., & Rowe, W. P. (1966) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.55.6.1467 · Cited by 536
Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors
Bartlett, J. S., Wilcher, R., & Samulski, R. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2777-2785.2000 · Cited by 532
Self-citationDavidson, B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., Zabner, J., Ghodsi, A., & Chiorini, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3428 · Cited by 531 · cited 1×
“Davidson et al (2000) crosspackaged AAV2 ITR into AAV4 capsid and compared the transduction efficiency of this virus in the central nervous system to AAV5 vector containing a genome with AAV5 ITR [Davidson, BL et al., 2000].”
The Three-Dimensional Structure of Canine Parvovirus and Its Functional Implications
Tsao, J., Chapman, M. S., Agbandje, M., Keller, W., Smith, K., Wu, H., Luo, M., Smith, T. J., Rossmann, M. G., Compans, R. W., et al. (1991) · Science · doi:10.1126/science.2006420 · Cited by 512
Samulski, R. J., Berns, K. I., Tan, M., & Muzyczka, N. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.6.2077 · Cited by 466
Self-citationRutledge, E. A., Halbert, C. L., & Russell, D. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.309-319.1998 · Cited by 452
McCown, T. J., Xiao, X., Li, J., Breese, G. R., & Jude Samulski, R. (1996) · Brain Research · doi:10.1016/0006-8993(95)01488-8 · Cited by 450
Self-citationHuman fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., & Srivastava, A. (1999) · Nature Medicine · doi:10.1038/4758 · Cited by 443
Kaludov, N., Brown, K. E., Walters, R. W., Zabner, J., & Chiorini, J. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.6884-6893.2001 · Cited by 427 · cited 1×
“Kaludov et al. (2002) described a two step purification utilizing an anion-exchange column and high molecular weight retention filters [Kaludov, N et al.”
MethodMüller, O. J., Kaul, F., Weitzman, M. D., Pasqualini, R., Arap, W., Kleinschmidt, J. A., & Trepel, M. (2003) · Nature Biotechnology · doi:10.1038/nbt856 · Cited by 410
Snyder, R. O., Miao, C., Meuse, L., Tubb, J., Donahue, B. A., Lin, H.-F., Stafford, D. W., Patel, S., Thompson, A. R., Nichols, T., et al. (1999) · Nature Medicine · doi:10.1038/4751 · Cited by 409
Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2
Girod, A., Ried, M., Wobus, C., Lahm, H., Leike, K., Kleinschmidt, J., Deléage, G., & Hallek, M. (1999) · Nature Medicine · doi:10.1038/12491 · Cited by 405
Auricchio, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.26.3075 · Cited by 403
Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus
Duan, D., Yue, Y., Yan, Z., Yang, J., & Engelhardt, J. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8317 · Cited by 391
Wu, P., Xiao, W., Conlon, T., Hughes, J., Agbandje-McKenna, M., Ferkol, T., Flotte, T., & Muzyczka, N. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8635-8647.2000 · Cited by 390 · cited 2×
“For example, Wu et al. (2000) demonstrated that alanine substitution at specific capsid positions carrying charged amino acids generated mutant viruses that were not able to assemble (amino acids 228–232, 235–239, 285–289, 291–295, 307–311, 607–611, 681–683, 689–693).”
BackgroundOpie, S. R., Warrington, Agbandje-McKenna, M., Zolotukhin, S., & Muzyczka, N. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6995-7006.2003 · Cited by 364
Binding of Adeno-associated Virus Type 5 to 2,3-Linked Sialic Acid Is Required for Gene Transfer
Walters, R. W., Yi, S. M. P., Keshavjee, S., Brown, K. E., Welsh, M. J., Chiorini, J. A., & Zabner, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101559200 · Cited by 363
Identification of PDGFR as a receptor for AAV-5 transduction
Pasquale, G. D., Davidson, B. L., Stein, C. S., Martins, I., Scudiero, D., Monks, A., & Chiorini, J. A. (2003) · Nature Medicine · doi:10.1038/nm929 · Cited by 355
Cloning and Characterization of Adeno-Associated Virus Type 5
Chiorini, J. A., Kim, F., Yang, L., & Kotin, R. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1309-1319.1999 · Cited by 332
Regulated Delivery of Therapeutic Proteins After in Vivo Somatic Cell Gene Transfer
Ye, X., Rivera, V. M., Zoltick, P., Cerasoli, F., Schnell, M. A., Gao, G.-P., Hughes, J. V., Gilman, M., & Wilson, J. M. (1999) · Science · doi:10.1126/science.283.5398.88 · Cited by 308
Song, S., Morgan, M., Ellis, T., Poirier, A., Chesnut, K., Wang, J., Brantly, M., Muzyczka, N., Byrne, B. J., Atkinson, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14384 · Cited by 304
Douar, A.-M., Poulard, K., Stockholm, D., & Danos, O. (2001) · Journal of Virology · doi:10.1128/jvi.75.4.1824-1833.2001 · Cited by 282
Sanlioglu, S., Benson, P. K., Yang, J., Atkinson, E. M., Reynolds, T., & Engelhardt, J. F. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9184-9196.2000 · Cited by 269
The cryptic life style of adenoassociated virus
Berns, K. I., & Linden, R. M. (1995) · BioEssays · doi:10.1002/bies.950170310 · Cited by 268
Hepatocyte Growth Factor Receptor Is a Coreceptor for Adeno-Associated Virus Type 2 Infection
Kashiwakura, Y., Tamayose, K., Iwabuchi, K., Hirai, Y., Shimada, T., Matsumoto, K., Nakamura, T., Watanabe, M., Oshimi, K., & Daida, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.609-614.2005 · Cited by 246
Mori, S., Wang, L., Takeuchi, T., & Kanda, T. (2004) · Virology · doi:10.1016/j.virol.2004.10.012 · Cited by 245
Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles
Chiorini, J. A., Yang, L., Liu, Y., Safer, B., & Kotin, R. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6823-6833.1997 · Cited by 231
Bartlett, J. S., Kleinschmidt, J., Boucher, R. C., & Samulski, R. J. (1999) · Nature Biotechnology · doi:10.1038/6185 · Cited by 230
Self-citationIn vitro selection of viral vectors with modified tropism: the adeno-associated virus display
Perabo, L., Büning, H., Kofler, D. M., Ried, M. U., Girod, A., Wendtner, C. M., Enssle, J., & Hallek, M. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00123-0 · Cited by 229
Yan, Z., Zak, R., Luxton, G. W. G., Ritchie, T. C., Bantel-Schaal, U., & Engelhardt, J. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2043-2053.2002 · Cited by 222
Efficient and Selective AAV2-Mediated Gene Transfer Directed to Human Vascular Endothelial Cells
Nicklin, S. A., Buening, H., Dishart, K. L., de Alwis, M., Girod, A., Hacker, U., Thrasher, A. J., Ali, R. R., Hallek, M., & Baker, A. H. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0424 · Cited by 219
Hybrid Vectors Based on Adeno-Associated Virus Serotypes 2 and 5 for Muscle-Directed Gene Transfer
Hildinger, M., Auricchio, A., Gao, G., Wang, L., Chirmule, N., & Wilson, J. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6199-6203.2001 · Cited by 207
Warrington, K. H., Gorbatyuk, O. S., Harrison, J. K., Opie, S. R., Zolotukhin, S., & Muzyczka, N. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6595-6609.2004 · Cited by 205 · cited 2×
“Warrington et al. (2004) described a VP2-N-terminal GFP-tagged virus to perform real-time imaging to study viral trafficking [Sanlioglu, S et al., 2000; Warrington, KH, Jr. et al., 2004].”
BackgroundThe structure of human parvovirus B19
Kaufmann, B., Simpson, A. A., & Rossmann, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402992101 · Cited by 204
Monahan, P., Samulski, R., Tazelaar, J., Xiao, X., Nichols, T., Bellinger, D., Read, M., & Walsh, C. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300548 · Cited by 202
Self-citationUse of adeno-associated viral vector for delivery of small interfering RNA
Tomar, R. S., Matta, H., & Chaudhary, P. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206733 · Cited by 196
Structural Proteins of Adenovirus-Associated Viruses
Rose, J. A., Maizel, J. V., Inman, J. K., & Shatkin, A. J. (1971) · Journal of Virology · doi:10.1128/jvi.8.5.766-770.1971 · Cited by 190
Characterization of the DNA of a defective human parvovirus isolated from a genital site
Bantel-Schaal, U., & Zur Hausen, H. (1984) · Virology · doi:10.1016/0042-6822(84)90271-x · Cited by 188
Dynamin Is Required for Recombinant Adeno-Associated Virus Type 2 Infection
Duan, D., Li, Q., Kao, A. W., Yue, Y., Pessin, J. E., & Engelhardt, J. F. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10371-10376.1999 · Cited by 186
Structure determination of feline panleukopenia virus empty particles
Agbandje, M., McKenna, R., Rossmann, M. G., Strassheim, M. L., & Parrish, C. R. (1993) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340160204 · Cited by 172
During, M., Samulski, R., Elsworth, J., Kaplitt, M., Leone, P., Xiao, X., Li, J., Freese, A., Taylor, Jr., Roth, R., et al. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300650 · Cited by 171
Self-citationRabinowitz, J. E., Bowles, D. E., Faust, S. M., Ledford, J. G., Cunningham, S. E., & Samulski, R. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4421-4432.2004 · Cited by 171
Self-citationScalable Purification of Adeno-Associated Virus Type 2, 4, or 5 Using Ion-Exchange Chromatography
Kaludov, N., Handelman, B., & Chiorini, J. A. (2002) · Human Gene Therapy · doi:10.1089/104303402320139014 · Cited by 167
Shi, W., Arnold, G. S., & Bartlett, J. S. (2001) · Human Gene Therapy · doi:10.1089/104303401750476212 · Cited by 167
Shi, W., & Bartlett, J. S. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00042-x · Cited by 164
Generation and characterization of chimeric recombinant AAV vectors
Hauck, B., Chen, L., & Xiao, W. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00012-1 · Cited by 160
Nucleotide Sequencing and Generation of an Infectious Clone of Adeno-Associated Virus 3
Muramatsu, S.-I., Mizukami, H., Young, N. S., & Brown, K. E. (1996) · Virology · doi:10.1006/viro.1996.0367 · Cited by 159
Song, S., Embury, J. E., Laipis, P., Berns, K., Crawford, J., & Flotte, T. R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301422 · Cited by 150
Hansen, J., Qing, K., Kwon, H.-J., Mah, C., & Srivastava, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.2.992-996.2000 · Cited by 147
Wistuba, A., Weger, S., Kern, A., & Kleinschmidt, J. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5311-5319.1995 · Cited by 147
Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers
Weitzman, M. D., Fisher, K. J., & Wilson, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1845-1854.1996 · Cited by 140
Adenovirus-Facilitated Nuclear Translocation of Adeno-Associated Virus Type 2
Xiao, W., Warrington, K. H., Hearing, P., Hughes, J., & Muzyczka, N. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11505-11517.2002 · Cited by 137
Insertional Mutagenesis of AAV2 Capsid and the Production of Recombinant Virus
Rabinowitz, J. E., Xiao, W., & Samulski, R. J. (1999) · Virology · doi:10.1006/viro.1999.0045 · Cited by 136
Self-citationPonnazhagan, S., Mahendra, G., Kumar, S., Thompson, J. A., & Castillas (2002) · Journal of Virology · doi:10.1128/jvi.76.24.12900-12907.2002 · Cited by 129
Hansen, J., Qing, K., & Srivastava, A. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4080-4090.2001 · Cited by 129
The structure of an insect parvovirus (Galleria mellonella densovirus) at 3.7 å resolution
Simpson, A. A., Chipman, P. R., Baker, T. S., Tijssen, P., & Rossmann, M. G. (1998) · Structure · doi:10.1016/s0969-2126(98)00136-1 · Cited by 128
Yang, Q., Mamounas, M., Yu, G., Kennedy, S., Leaker, B., Merson, J., Wong-Staal, F., Yu, M., & Barber, J. R. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.13-1929 · Cited by 127
Alexander, I. E., Russell, D. W., Spence, A. M., & Miller, A. D. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.7-841 · Cited by 124
Qing, K., Khuntirat, B., Mah, C., Kube, D. M., Wang, X.-S., Ponnazhagan, S., Zhou, S., Dwarki, V. J., Yoder, M. C., & Srivastava, A. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1593-1599.1998 · Cited by 121
Physical Assay and Growth Cycle Studies of a Defective Adeno-Satellite Virus
Parks, W. P., Melnick, J. L., Rongey, R., & Mayor, H. D. (1967) · Journal of Virology · doi:10.1128/jvi.1.1.171-180.1967 · Cited by 118
Conway, J. E., Zolotukhin, S., Muzyczka, N., Hayward, G. S., & Byrne, B. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8780-8789.1997 · Cited by 115
Structure of Adeno-Associated Virus Serotype 5
Walters, R. W., Agbandje-McKenna, M., Bowman, V. D., Moninger, T. O., Olson, N. H., Seiler, M., Chiorini, J. A., Baker, T. S., & Zabner, J. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3361-3371.2004 · Cited by 114
Loiler, S., Conlon, T. J., Song, S., Tang, Q., Warrington, K. H., Agarwal, A., Kapturczak, M., Li, C., Ricordi, C., Atkinson, M. A., et al. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302046 · Cited by 110
Chipman, P. R., Agbandje-McKenna, M., Kajigaya, S., Brown, K. E., Young, N. S., Baker, T. S., & Rossmann, M. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7502 · Cited by 106
Adeno-Associated Virus Type 2 Protein Interactions: Formation of Pre-Encapsidation Complexes
Dubielzig, R., King, J. A., Weger, S., Kern, A., & Kleinschmidt, J. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.8989-8998.1999 · Cited by 105
Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis
Cottard, V., Mulleman, D., Bouillé, P., Mezzina, M., Boissier, M., & Bessis, N. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301324 · Cited by 100
Cloning of an Avian Adeno-Associated Virus (AAAV) and Generation of Recombinant AAAV Particles
Bossis, I., & Chiorini, J. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6799-6810.2003 · Cited by 93
A Single-Step Affinity Column for Purification of Serotype-5 Based Adeno-associated Viral Vectors
Auricchio, A., O'Connor, E., Hildinger, M., & Wilson, J. M. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0462 · Cited by 91
Structure Determination of Minute Virus of Mice
Llamas-Saiz, A. L., Agbandje-McKenna, M., Wikoff, W. R., Bratton, J., Tattersall, P., & Rossmann, M. G. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996010566 · Cited by 87
Cloning and Characterization of a Bovine Adeno-Associated Virus
Schmidt, M., Katano, H., Bossis, I., & Chiorini, J. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6509-6516.2004 · Cited by 83
Chiorini, J. A., Afione, S., & Kotin, R. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4293-4298.1999 · Cited by 78
Li, J., Wang, D., Qian, S., Chen, Z., Zhu, T., & Xiao, X. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302078 · Cited by 69
A parvovirus isolated from royal python (Python regius) is a member of the genus Dependovirus
Farkas, S. L., Zádori, Z., Benkő, M., Essbauer, S., Harrach, B., & Tijssen, P. (2004) · Journal of General Virology · doi:10.1099/vir.0.19616-0 · Cited by 67
Role of Viral Vectors and Virion Shells in Cellular Gene Expression
Stilwell, J. L., & Samulski, R. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.11.007 · Cited by 67
Self-citationBowles, D. E., Rabinowitz, J. E., & Samulski, R. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.1.423-432.2003 · Cited by 67
Self-citationPonnazhagan, S., Wang, X.-S., Woody, M. J., Luo, F., Kang, L. Y., Nallari, M. L., Munshi, N. C., Zhou, S. Z., & Srivastava, A. (1996) · Journal of General Virology · doi:10.1099/0022-1317-77-6-1111 · Cited by 64
Viral receptors and vector purification: New approaches for generating clinical-grade reagents
Summerford, C., & Samulski, R. J. (1999) · Nature Medicine · doi:10.1038/8470 · Cited by 59
Self-citationLarge-scale production, purification and crystallization of wild-type adeno-associated virus-2
Xie, Q., Hare, J. T., Turnigan, J., & Chapman, M. S. (2004) · Journal of Virological Methods · doi:10.1016/j.jviromet.2004.07.007 · Cited by 58
Coinfection of a Bearded Dragon, Pogona vitticeps , with Adenovirus- and Dependovirus-like Viruses
Jacobson, E. R., Kopit, W., Kennedy, F. A., & Funk, R. S. (1996) · Veterinary Pathology · doi:10.1177/030098589603300313 · Cited by 53
Attenuation of dengue virus infection by adeno-associated virus-mediated siRNA delivery
Zhang, W., Singam, R., Hellermann, G., Kong, X., San-Juan-Vergara, H. G., Lockey, R. F., Wu, S.-J., Porter, K. R., & Mohapatra, S. S. (2004) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-2-8 · Cited by 46
Han, W., Wind‐Rotolo, M., Kirkman, R. L., & Morrow, C. D. (2004) · Virology · doi:10.1016/j.virol.2004.09.027 · Cited by 41
Zhang, H.-G., Xie, J., Dmitriev, I., Kashentseva, E., Curiel, D. T., Hsu, H.-C., & Mountz, J. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.23.12023-12031.2002 · Cited by 39 · cited 1×
“In a different study, Zhang et al (2002) described a chimeric AAV, composed of wt AAV VP1 and 2 proteins, and a C-terminal 6-His-tagged VP3, which yielded infectious and wt-like virus that can be readily purified by using a Ninitrilotriacetic acid column [Zhang, HG et al., 2002].”
MethodComputational and experimental analysis of DNA shuffling
Maheshri, N., & Schaffer, D. (2003) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0537968100 · Cited by 38
Inhibition of NF-κB mediated inflammation by siRNA expressed by recombinant adeno-associated virus
Pinkenburg, O., Platz, J., Beißwenger, C., Vogelmeier, C. F., & Bals, R. (2004) · Journal of Virological Methods · doi:10.1016/j.jviromet.2004.04.007 · Cited by 38
Kaludov, N. K., Padron, E., Govindasamy, L., McKENNA, R. V., Chiorini, J. A., & Agbandje‐McKenna, M. (2003) · Virology · doi:10.1016/s0042-6822(02)00037-5 · Cited by 32
Isolation of an adeno associated virus from sheep
Clarke, J. K., McFerran, J. B., McKillop, E. R., & Curran, W. L. (1979) · Archives of Virology · doi:10.1007/bf01348034 · Cited by 26
Isolation of an Adenovirus and an Adeno-Associated Virus from Goat Kids with Enteritis
Olson, E. J., Haskell, S. R. R., Frank, R. K., Lehmkuhl, H. D., Hobbs, L. A., Warg, J. V., Landgraf, J. G., & Wünschmann, A. (2004) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/104063870401600518 · Cited by 25
Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy.
Flotte, T. R. (2001) · PubMed · Cited by 24
Amiss, T. J., McCarty, D. M., Skulimowski, A., & Samulski, R. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.3.1904-1915.2003 · Cited by 22
Self-citationAsfour, B., Baba, H. A., Scheld, H. H., Hruban, R. H., Hammel, D., & Byrne, B. J. (2002) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/s-2002-35745 · Cited by 18
Cited by
Optogenetics in neural systems
Yizhar, O., Fenno, L. E., Davidson, T. J., Mogri, M., & Deisseroth, K. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.004 · Cited by 1,881
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406
Adeno-associated Virus Serotypes: Vector Toolkit for Human Gene Therapy
Wu, Z., Asokan, A., & Samulski, R. J. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.009 · Cited by 922
“These studies have been reviewed elsewhere [9,10].”
Self-citationGrimm, D., Lee, J. S., Wang, L., Desai, T., Akache, B., Storm, T. A., & Kay, M. A. (2008) · Journal of Virology · doi:10.1128/jvi.00254-08 · Cited by 696
State-of-the-art gene-based therapies: the road ahead
Kay, M. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2971 · Cited by 666
“Improved vectors have also been obtained by experimentally modifying the capsid sequence with site-specific mutations, by using hybrid capsid”
Metadata
- Authors
- Choi, V., McCarty, D., & Samulski, R.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Venue
- Current Gene Therapy
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2005-06-01
- Volume
- 5
- Issue
- 3
- Pages
- 299-310
- ISSN
- 1566-5232 (ISSN-L)
- PMC
- PMC1462937
- OpenAlex
- W2160121070
- Cited by
- 191
- References
- 108
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 9 · 2020: 7 · 2019: 9 · 2018: 3 · 2017: 8 · 2016: 5 · 2015: 12 · 2014: 14 · 2013: 12 · 2012: 13
- FWCI
- 7.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Current Gene Therapy (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health (5p01gm059299-10)
- National Heart, Lung, and Blood Institute (HL051818, P01HL051818, P01HL066973, HL 066973)
- National Institute of General Medical Sciences (P01 GM-059299)
- National Institute of Allergy and Infectious Diseases (R01AI048074, AI048074)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- adeno-associated virus, AAV capsid engineering, gene delivery vectors, receptor binding, viral trafficking
- MeSH terms
- Dependovirus, Animals, Genetic Vectors, Humans, Recombination, Genetic, Serotyping, Genetic Therapy, Gene Transfer Techniques, Capsid Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.